Patent Law Weblog
recent posts
- Constellation Designs, LLC v. LG Electronics Inc. (Fed. Cir. 2026)
- Actelion Pharmaceuticals Ltd. v. Mylan Pharmaceuticals Inc. (Fed. Cir. 2026)
- PTAB Reverses § 101 Rejection Where Examiner Failed to Follow the Office’s Own Guidance
- Collision Communications v. Samsung: What Good Did the Government’s Statement of Interest Do?
- United States Files Statement of Interest in Patent Infringement Proceedings
about
Month: June 2012
-
The Intellectual Property Owners Association (IPO) will be holding its 40th Annual Meeting on September 9-11, 2012 in San Antonio, TX. Among the presentations being offered at the annual meeting are: • Patent Case Law Update• The America Invents Act – What Should Your Company or Client be Doing?• IPO's Corporate IP Benchmarking Survey: A…
-
By James DeGiulio — In a history-making decision, the Supreme Court today in National Federation of Independent Business v. Sebelius upheld the Patient Protection and Affordable Care Act (PPACA) as constitutional under the taxation clause of the Constitution. The individual mandate provision of the PPACA, which establishes the requirement that nearly all Americans secure "minimum…
-
By Kevin E. Noonan — We are living in an age of retrenchment with regard to patent law, where thirty years of Federal Circuit precedent, from the court created by Congress to harmonize U.S. patent law to great public benefit, is being reconsidered by the inconstant, almost fickle attention of the U.S. Supreme Court. This…
-
By Kevin E. Noonan — Every year, Steve Burrill, President and CEO of Burrill & Co. takes the stage at the BIO International Convention and spends 90 minutes giving the audience his take on the state of the biotech nation. And every year he has a theme: upbeat optimism in 2008 followed by downright pessimism…
-
By Donald Zuhn — In a notice published in today's Federal Register, the U.S. Patent and Trademark Office announced that it will be hosting a Cooperative Patent Classification (CPC) External User Day event from 8:30 am to 12:00 pm (EST) on July 10, 2012 (77 Fed. Reg. 37879). During the event, which will be held…
-
By Sherri Oslick — About Court Report: Each week we will report briefly on recently filed biotech and pharma cases. Bristol-Myers Squibb Company v. Sandoz Inc.1:12-cv-00787; filed June 21, 2012 in the District Court of Delaware Infringement of U.S. Patent No. 5,206,244 ("Hydroxymethyl (Methylenecyclopentyl) Purines and Pyrimidines," issued April 27, 1993) following a Paragraph IV…
-
June 24-26, 2012 – IP Business Congress (Intellectual Asset Management (IAM) magazine) – Cascais, Portugal June 25-26, 2012 – Hatch-Waxman Boot Camp*** (American Conference Institute) – San Diego, CA July 11-13, 2012 – Fundamentals of Patent Prosecution 2012: A Boot Camp for Claim Drafting & Amendment Writing (Practising Law Institute) – San Francisco, CA July…
-
The Institute for International Research (IIR) will be holding its 13th Annual Business of Biosimilars & Generic Drugs conference from September 10-12, 2012 in Boston, MA. The conference offer presentations on the following topics: September 10 — Summits• Biosimilar R&D Scenario Planning Session• Map the Strengths, Weaknesses, and Defenses of your IP Assets to Prepare…
-
Strafford will be offering a webinar/teleconference entitled "USPTO Post-Grant Proceedings: Meeting the New Requirements for Post-Grant and Inter Partes Reviews and Supplemental Examination" on August 2, 2012 from 1:00 – 2:30 pm (EDT). Greg H. Gardella, Scott A. McKeown, and Jessica J. Harrison of Oblon Spivak McClelland Maier & Neustadt will provide guidance on post-grant…
-
By Donald Zuhn — USPTO Extends After Final Consideration Pilot Program In March, the U.S. Patent and Trademark Office implemented an After Final Consideration Pilot (AFCP) program, which provided examiners with a limited amount of non-production time — three hours for utility, plant, and reissue applications and one hour for design applications — to consider…
Patent Docs 